Amedeo Lonardo
Amedeo Lonardo
Medicina Interna USL Modena
Verified email at
Cited by
Cited by
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis
G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui
Journal of hepatology 65 (3), 589-600, 2016
Sex and gender: modifiers of health, disease, and medicine
F Mauvais-Jarvis, NB Merz, PJ Barnes, RD Brinton, JJ Carrero, ...
The Lancet 396 (10250), 565-582, 2020
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome
A Lonardo, S Ballestri, G Marchesini, P Angulo, P Loria
Digestive and Liver disease 47 (3), 181-190, 2015
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review andá…
S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ...
Journal of gastroenterology and hepatology 31 (5), 936-944, 2016
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes
M Ricchi, MR Odoardi, L Carulli, C Anzivino, S Ballestri, A Pinetti, ...
Journal of gastroenterology and hepatology 24 (5), 830-840, 2009
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ...
Hepatology 70 (4), 1457-1469, 2019
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?
A Lonardo, F Nascimbeni, A Mantovani, G Targher
Journal of hepatology 68 (2), 335-352, 2018
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
A Lonardo, LE Adinolfi, P Loria, N Carulli, G Ruggiero, CP Day
Gastroenterology 126 (2), 586-597, 2004
Clinical Patterns of HepatocellularCarcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
and Fabio Piscaglia,1 Gianluca Svegliati-Baroni, Andrea Barchetti, Anna ...
HEPATOLOGY 63 (NO. 3), 827-838, 0
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ...
Digestive and Liver Disease 47 (12), 997-1006, 2015
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ...
Advances in therapy 34, 1291-1326, 2017
From NAFLD in clinical practice to answers from guidelines
F Nascimbeni, R Pais, S Bellentani, CP Day, V Ratziu, P Loria, A Lonardo
Journal of hepatology 59 (4), 859-871, 2013
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus
G Targher, A Lonardo, CD Byrne
Nature reviews endocrinology 14 (2), 99-114, 2018
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expertá…
P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ...
Digestive and Liver Disease 42 (4), 272-282, 2010
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
S Ballestri, A Lonardo, S Bonapace, CD Byrne, P Loria, G Targher
World journal of gastroenterology: WJG 20 (7), 1724, 2014
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis
A Mantovani, G Zaza, CD Byrne, A Lonardo, G Zoppini, E Bonora, ...
Metabolism 79, 64-76, 2018
Nonalcoholic fatty liver disease and aging: epidemiology to management
M Bertolotti, A Lonardo, C Mussi, E Baldelli, E Pellegrini, S Ballestri, ...
World journal of gastroenterology: WJG 20 (39), 14185, 2014
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ...
Digestive and Liver Disease 49 (5), 471-483, 2017
Non-alcoholic fatty liver disease and risk of cardiovascular disease
A Lonardo, S Sookoian, CJ Pirola, G Targher
Metabolism 65 (8), 1136-1150, 2016
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
LE Adinolfi, L Restivo, R Zampino, B Guerrera, A Lonardo, L Ruggiero, ...
Atherosclerosis 221 (2), 496-502, 2012
The system can't perform the operation now. Try again later.
Articles 1–20